ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000265912.1	Selumetinib	Breast invasive carcinoma	0.036718498	Resistant
ENSG00000265912.1	Selumetinib	Colon adenocarcinoma	0.035297252	Sensitive